Extract notice to the Minister

Ran-Gliclazide MR

Common name / Subject : gliclazide
Name of the manufacturer : Ranbaxy
Form : Co. L.A.
Dosage : 60 mg

Indication :

INESSS' Recommendation
Avis d'inscription aux listes des médicaments - Médicament d'exception

Minister's decisions
Inscrire aux listes des médicaments - Médicament d’exception

Evaluation published on August 19, 2016

Subscribe to our newsletter now

Subscription